Evidence map›Paper›PMID 29924220›Full record

ArticleAnais brasileiros de dermatologia2018

Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B.

Vanessa da Silva Fay, Diana Mara Garcia Rodrigues, Stela Maris Bottin Gonçalves, Tatiana Schaffer Gregianini, Renan Rangel Bonamigo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Anais brasileiros de dermatologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vanessa da Silva FayProgram of Post-Graduation in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil.
Diana Mara Garcia RodriguesInstituto de Pesquisas Biológicas, Laboratório Central, Secretaria de Saúde do Estado do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Stela Maris Bottin GonçalvesInstituto de Pesquisas Biológicas, Laboratório Central, Secretaria de Saúde do Estado do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Tatiana Schaffer GregianiniInstituto de Pesquisas Biológicas, Laboratório Central, Secretaria de Saúde do Estado do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Renan Rangel BonamigoProgram of Post-Graduation in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk diffusion method. In 2015, 82 emerging fungi were evaluated in IPB-LACEN/RS and 13 (15.8%) were resistant: 10/52 were from superficial mycoses and 3/30 from systemic mycoses. The data from the study point to the need for permanent vigilance regarding the careful evaluation in the prescription and clinical and laboratory follow-up of patients affected by fungal infections.

Indexed as

Drug Resistance, FungalAdultAgedAmphotericin BAntifungal AgentsFemaleFluconazoleFungiHIV InfectionsHumansItraconazoleMaleMicrobial Sensitivity TestsMycosesAmphotericin BAntifungal AgentsFluconazoleItraconazole

Identifiers

PMID29924220
PMCPMC6001099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.